SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 33,732 shares at $6.46 ($218K) on 2016-05-19, disclosed to the SEC on 2016-05-23.
Open-market sale of $218k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.46 | 3,748 | $24K | 11.1% |
| 2 | $6.45 | 14,992 | $97K | 44.4% |
| 3 | $6.45 | 14,992 | $97K | 44.4% |
| Total | $6.45 avg | 33,732 | $218K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-04 | $689K | — | Filing → |
| REPH | SELL | 2018-01-02 | $338K | — | Filing → |